Clinical Trial Update: EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating carboplatin and paclitaxel with or without nivolumab in metastatic or unresectable anal cancer, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Basaloid Carcinoma
• Anal Canal Cloacogenic Carcinoma
• Anal Cancer Ajcc V8
• Anal Squamous Cell Carcinoma
• Unresectable Anal Squamous Cell Carcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING